|Outcomes at mean 4.1 years||HRT||Placebo||RRI (95% CI)||NNH (CI)|
|†Abbreviations defined in glossary; RRI, NNH, and CI calculated from data in article.|
|Any venous thromboembolic event||2.5%||0.9%||162% (40 to 390)||66 (39 to 172)|
|Deep venous thrombosis||1.8%||0.7%||178% (33 to 484)||86 (48 to 279)|
|Non-idiopathic venous thromboembolic event||1.8%||0.7%||151% (23 to 412)||92 (50 to 372)|
|Pulmonary embolism||0.8%||0.3%||176% (−7 to 718)||Not significant|
|Idiopathic venous thromboembolic event||0.7%||0.2%||201% (−12 to 925)||Not significant|
Oestrogen plus progestin increased venous thromboembolic disease in postmenopausal women with coronary artery disease
EBN Twitter Journal Club
The club runs like other journal discussion groups, except that the article and questions are posted on this blog and
the discussion about the article happens on Twitter.
How to participate >>
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.